Health Times reporter Wang Zhenya
On December 21, the HPV vaccination program for school-age girls in Lianyungang City was officially launched in Lianyun District. Parents of students who came to the scene to be vaccinated told the Health Times reporter that "it is very fortunate that their children can be the first batch of people in Jiangsu to get the free HPV vaccine."
"We are giving HPV vaccination vouchers to student representatives, and this time we will give nearly 700 girls free HPV vaccination." The staff of the Lianyungang Municipal Health Commission told the Health Times reporter that in Lianyungang City, girls in the eighth grade will receive 2 free doses of domestic bivalent HPV vaccine. Starting in 2022, THE CITY OF LIANYUNGANG WILL CARRY OUT HPV VACCINATION FOR SEVENTH GRADE GIRLS EVERY YEAR.
Jiangsu Lianyungang HPV vaccine free of charge first dose. Photo courtesy of Lianyungang Health Commission
The HPV vaccination of junior high school girls can make the long-term goal of eliminating cervical cancer by 2030 be achieved earlier, and the first injection was launched in Lianyungang and the first injection in the national candidate pilot city.
In December, Jiangsu Province issued the "14th Five-Year Plan" Development Plan for Women and Children, encouraging qualified areas to promote HPV vaccination with a focus on girls aged 9 to 15 years old. Lianyungang City actively responded to the call and took the lead in carrying out HPV vaccination in Jiangsu Province for the comprehensive prevention and treatment of cervical cancer in Lianyun District.
Girls of appropriate age are vaccinated. Photo courtesy of Lianyungang Health Commission
According to the preliminary arrangement, Lianyun District eighth grade girls of the right age to vaccinate strongly, 95% of girls voluntarily vaccinated, according to the staff of Lianyungang Municipal Health Commission, Lianyungang Lianyun District a total of 7 community health service centers, parents can take their children to the nearest vaccination.
The vaccination is a domestic bivalent HPV vaccine produced by Xiamen Wantai. In October this year, the vaccine has been officially certified by the World Health Organization PQ, and more than 7 million doses have been administered so far, and the safety and efficacy have been verified.